Vasoactive intestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cells
Ana Valdehíta(Universidad de Alcalá), Ana M. Bajo(Universidad de Alcalá), Marı́a J. Carmena(Universidad de Alcalá), Juan Carlos Prieto(Universidad de Santiago de Chile), Beatriz Collado(Universidad de Alcalá)
Cited by 35
Related Papers
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755
Synergism between paracetamol and nonsteroidal anti-inflammatory drugs in experimental acute pain
|Pain|2006|187
A deep neural network to assess spontaneous pain from mouse facial expressions
|Molecular Pain|2018|174
Interaction of vasoactive intestinal peptide with human blood mononuclear cells
|Molecular and Cellular Endocrinology|1981|149
Osteoarthritis of the Temporomandibular Joint can be diagnosed earlier using biomarkers and machine learning
|Scientific Reports|2020|130